ERRA has also shown to mediate the adaption of metabolic systems to the tumour microenvironment and could be involved in the direct activation of Wnt11/β-catenin pathway, and this in turn leads to an increase in the capacity of cells to migrate66. The gene discussed is WNT11; the disease is neoplasm.